FORTREA HOLDINGS INC. Investing Cash Flow
FORTREA HOLDINGS INC. (FTRE) reported Investing Cash Flow of -$15.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-29
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$7.00M.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$8.00M, a 149.69% decline year-over-year.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$7.50M, a 314.29% decline year-over-year.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $13.30M.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2025 was $14.40M, a 94.28% decline from fiscal 2024.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2024 was $251.60M.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2023 was -$31.80M.
- FORTREA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2022 was -$54.00M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$15.00M 10-Q · filed 2026-07-29 | -$22.50M derived: sum of 3 quarters · filed 2026-07-29 | -$9.20M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$8.00M 10-Q · filed 2026-05-05 | -$15.50M derived: sum of 2 quarters · filed 2026-05-05 | -$2.20M derived: sum of 3 quarters · filed 2026-05-05 | -$9.70M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.80M derived: sum of 2 quarters · filed 2026-02-26 | -$1.70M derived: sum of 3 quarters · filed 2026-07-29 | $14.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.80M derived: sum of 2 quarters · filed 2026-07-29 | $21.90M 10-Q · filed 2025-11-05 | $25.40M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $8.60M 10-Q · filed 2026-07-29 | $12.10M derived: sum of 3 quarters · filed 2026-07-29 | $4.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $16.10M 10-Q · filed 2026-05-05 | $19.60M derived: sum of 2 quarters · filed 2026-05-05 | $11.50M derived: sum of 3 quarters · filed 2026-05-05 | $276.90M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.60M derived: sum of 2 quarters · filed 2026-02-26 | $260.80M derived: sum of 3 quarters · filed 2026-02-26 | $251.60M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $257.30M derived: sum of 2 quarters · filed 2025-11-05 | $248.10M 10-Q · filed 2025-11-05 | $239.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $265.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $256.20M 10-Q · filed 2025-08-06 | $247.20M derived: sum of 3 quarters · filed 2026-02-26 | $249.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$9.20M 10-Q · filed 2025-05-12 | -$18.20M derived: sum of 2 quarters · filed 2026-02-26 | -$15.50M derived: sum of 3 quarters · filed 2026-02-26 | -$24.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.30M derived: sum of 2 quarters · filed 2026-02-26 | -$15.60M derived: sum of 3 quarters · filed 2026-02-26 | -$31.80M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$6.60M derived: sum of 2 quarters · filed 2024-11-08 | -$22.80M 10-Q · filed 2024-11-08 | -$41.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$25.50M 10-Q · filed 2024-08-12 | -$43.90M derived: sum of 3 quarters · filed 2025-03-03 | -$60.80M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$16.20M 10-Q · filed 2024-05-24 | -$34.60M derived: sum of 2 quarters · filed 2025-03-03 | -$51.50M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | -$18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$35.30M derived: sum of 2 quarters · filed 2025-03-03 | -$54.00M 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$16.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$35.60M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$18.70M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | -$26.20M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |